ES455938A1 - Un procedimiento para la preparacion de nuevos derivados de biciclo (2,2,1) heptano. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de biciclo (2,2,1) heptano.

Info

Publication number
ES455938A1
ES455938A1 ES455938A ES455938A ES455938A1 ES 455938 A1 ES455938 A1 ES 455938A1 ES 455938 A ES455938 A ES 455938A ES 455938 A ES455938 A ES 455938A ES 455938 A1 ES455938 A1 ES 455938A1
Authority
ES
Spain
Prior art keywords
endo
alkyl
indolecarbonyloxy
bicyclo
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES455938A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES455938A1 publication Critical patent/ES455938A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nueva serie de imidas de ácido 5-endo-(3-indolcarboniloxi)-N-[aminoalquil (inferior)] biciclo [2.2.1] heptano-2, 3-di-endo carboxílico que poseen actividad anti-arrítmica y/o anti-fibrilatoria. La arritmia cardiaca, un fenómeno comúnmente asociado con las enfermedades cardiacas coronarias o con el infarto de miocardio. Se sospecha que el mecanismo de la arritmia cardiaca es causado por un "foco" anormal en el ventrículo del corazón que envía (enciende) señales nerviosas con mayor rapidez que la requerida para el latido normal del corazón. Se ha descubierto que la serie de compuestos aquí denominados imidas de ácido 5-endo (3-indolcarboniloxi)-N-[aminoalquil (inferior)]biciclo[2.2.1] heptano-2,3-di-endo-carboxílico son agentes terapéuticos o profilácticos útiles para suprimir el latido ectópico anormal.
ES455938A 1974-09-18 1977-02-15 Un procedimiento para la preparacion de nuevos derivados de biciclo (2,2,1) heptano. Expired ES455938A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50702974A 1974-09-18 1974-09-18
US05/594,918 US3980668A (en) 1974-09-18 1975-07-10 Anti-arrhythimic 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2,2,1]heptane-2,3-di-endo-carboxylic acid imides

Publications (1)

Publication Number Publication Date
ES455938A1 true ES455938A1 (es) 1978-02-01

Family

ID=27055675

Family Applications (2)

Application Number Title Priority Date Filing Date
ES441038A Expired ES441038A1 (es) 1974-09-18 1975-09-17 Un procedimiento para la preparacion de nuevos derivados de biciclo (2, 2, 1) heptano.
ES455938A Expired ES455938A1 (es) 1974-09-18 1977-02-15 Un procedimiento para la preparacion de nuevos derivados de biciclo (2,2,1) heptano.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES441038A Expired ES441038A1 (es) 1974-09-18 1975-09-17 Un procedimiento para la preparacion de nuevos derivados de biciclo (2, 2, 1) heptano.

Country Status (24)

Country Link
US (1) US3980668A (es)
JP (1) JPS6039669B2 (es)
AR (1) AR212235A1 (es)
AT (1) AT345275B (es)
CA (1) CA1068281A (es)
CH (1) CH615925A5 (es)
CS (1) CS187489B2 (es)
DD (1) DD123092A5 (es)
DE (1) DE2541434A1 (es)
DK (1) DK418075A (es)
ES (2) ES441038A1 (es)
FI (1) FI64352C (es)
FR (1) FR2313047A1 (es)
GB (1) GB1484214A (es)
HU (1) HU173807B (es)
IE (1) IE42051B1 (es)
IL (1) IL48096A (es)
LU (1) LU73418A1 (es)
NL (1) NL7510934A (es)
NO (1) NO144072C (es)
PH (1) PH11498A (es)
PL (2) PL101454B1 (es)
SE (1) SE421421B (es)
YU (2) YU40123B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557341A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung
US4139533A (en) * 1976-08-19 1979-02-13 Bristol-Myers Company Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850921A (en) * 1972-09-20 1974-11-26 I Matuo Derivatives of 2,3-norbornanedicarboxamide

Also Published As

Publication number Publication date
YU40123B (en) 1985-08-31
YU284082A (en) 1985-04-30
IL48096A (en) 1979-09-30
NO144072B (no) 1981-03-09
ES441038A1 (es) 1977-07-01
LU73418A1 (es) 1976-08-13
PL101454B1 (pl) 1978-12-30
NL7510934A (nl) 1976-03-22
SE7510362L (sv) 1976-03-19
IL48096A0 (en) 1975-11-25
AR212235A1 (es) 1978-06-15
CH615925A5 (es) 1980-02-29
IE42051B1 (en) 1980-05-21
GB1484214A (en) 1977-09-01
CS187489B2 (en) 1979-01-31
HU173807B (es) 1979-08-28
DD123092A5 (es) 1976-11-20
US3980668A (en) 1976-09-14
ATA718575A (de) 1978-01-15
FI752572A (es) 1976-03-19
NO144072C (no) 1981-06-17
CA1068281A (en) 1979-12-18
PH11498A (en) 1978-02-01
NO753128L (es) 1976-03-19
DK418075A (da) 1976-03-19
FR2313047B1 (es) 1979-09-14
FI64352C (fi) 1983-11-10
IE42051L (en) 1976-03-18
JPS51131871A (en) 1976-11-16
YU225375A (en) 1983-12-31
AU8459775A (en) 1977-03-10
DE2541434A1 (de) 1976-04-08
AT345275B (de) 1978-09-11
JPS6039669B2 (ja) 1985-09-06
SE421421B (sv) 1981-12-21
FR2313047A1 (fr) 1976-12-31
FI64352B (fi) 1983-07-29
PL100522B1 (pl) 1978-10-31

Similar Documents

Publication Publication Date Title
ES422395A1 (es) Un procedimiento para la preparacion de cinamamidas e hi- drocinamamidas.
CA1273019C (en) ENKEPHALINASE INHIBITORS
HUP0003250A1 (hu) Káliumcsatorna gátló hatású indánszármazékok és az ezeket tartalmazó gyógyszerkészítmények
ES435246A1 (es) Procedimiento para preparar derivados de piperidina.
ES455365A1 (es) Un metodo de preparacion de un peptido dotado de actividad biologica analoga a la de la morfina.
ES429234A1 (es) Procedimiento para la preparacion de nuevas amidas de aci- dos n-(1-(omega-fenilalcohil)-piperidil-4)-n-(alfa-piridil)-carboxilicos.
DE3476847D1 (en) A remedial or prophylactic agent for the treatment of seizures
IE41440L (en) Thiatetracyclines
ES455938A1 (es) Un procedimiento para la preparacion de nuevos derivados de biciclo (2,2,1) heptano.
IE44765L (en) N-substituted benzamides.
JPS5543077A (en) Preparation of 1,3-dithiolan-2-ylidenemalonate derivative
JPS6422883A (en) 1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
ES8104226A1 (es) Procedimiento para la preparacion de nuevas imidas de acido ciclobutandicarboxilico
ES436864A1 (es) Procedimiento de preparacion de las amino-2 imidazol.
FR2290203B1 (es)
GB1198019A (en) Process for the production of p-Aminobenzoic Acid Amides
ES432926A1 (es) Un procedimiento para preparar nuevos derivados de 1,3-ben-zodioxol.
IE41106L (en) Pharmaceutical compositions containing benzylamines
ES436374A1 (es) Un procedimiento para producir un derivado de halobis(ito- cianatometiltio)piridina.
GB2011407A (en) 4-oxo-nitrogen bridgehead compounds
ES380930A1 (es) Un procedimiento de preparacion de nuevas 2-hidroxi-5-aminobenzamidas.
GB967890A (en) Improvements in antibiotics
GB1500054A (en) 5-fluorouracil derivatives and preparation thereof
ES464753A1 (es) Procedimiento para producir nuevos derivados 6-sustituidos de d-8-ergolin-i-ilacetamida.